Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
1 hedge funds and large institutions have $2K invested in Zealand Pharma A/S American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 11 closing their positions.
91% less funds holding
Funds holding: 11 → 1 (-10)
91% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 11
100% less capital invested
Capital invested by funds: $10.4M → $2K (-$10.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TF
TimeScale Financial
Danvers,
Massachusetts
|
+$1.74K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$6.52M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2.87M |
| 3 |
AIC
AWM Investment Company
New York
|
-$631K |
| 4 |
Jane Street
New York
|
-$312K |
| 5 |
Morgan Stanley
New York
|
-$87K |
ZEAL Hedge Fund Activity: Q3 2022 in Review
1 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q3 2022, worth a combined $2K — down 100% from $10.4M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ZEAL and 1 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was TimeScale Financial, opening a new position worth an estimated $1.74K. The largest seller was Goldman Sachs, exiting entirely with an estimated $6.52M sold.
- 1 institutional investor held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q3 2022, down from 11 in Q2 2022.
- Funds reported $2K of Zealand Pharma A/S American Depositary Shares stock for Q3 2022, down 100% quarter-over-quarter.
- 1 fund opened new Zealand Pharma A/S American Depositary Shares positions in Q3 2022 and 11 closed out, a net change of -10 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q3 2022 was TimeScale Financial, an estimated $1.74K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q3 2022 was Goldman Sachs, an estimated $6.52M sold.
Based on aggregated 13F filings for Q3 2022.